Devastating new research from the American College of Surgeons has exposed the lethal consequences of cannabis-impaired driving, revealing that more than 40% of drivers killed in car crashes between 2019 and 2024 in Ohio tested positive for high levels of THC.
Moreover, the findings, released last week, shatter the persistent myth that cannabis is a harmless substance with no fatal consequences. Indeed, the data adds to mounting evidence that driving under the influence of marijuana poses a severe and growing threat to road safety across the United States.
Federal Data Confirms Rising Threat of Drug-Impaired Driving
Significantly, the Ohio study aligns with multiple federal investigations documenting the escalating danger of cannabis-impaired driving on American roads. For instance, a 2022 study by the National Traffic Safety Board found marijuana present in approximately one-third of all motorists arrested for impaired driving nationwide.
Furthermore, research from the National Highway Traffic Safety Administration that same year revealed that over 25% of individuals killed or seriously injured in road accidents who tested positive for any drug had used marijuana. Remarkably, this figure exceeded the 23% who tested positive for alcohol, therefore signalling a fundamental shift in road safety threats.
Perhaps most alarming is the widespread misunderstanding amongst cannabis users about the drug’s effects on driving ability. Consequently, a survey conducted by the Foundation for Traffic Safety earlier this year questioned 2,000 cannabis users, uncovering troubling attitudes towards drug-impaired driving.
Specifically, the research found that nearly 85% of cannabis users drive on the same day they consume marijuana. More concerningly, 81% believe that using cannabis either has no effect on their driving or actually improves it, a misconception with potentially fatal consequences.
In Virginia, for example, approximately 17% of residents admitted to driving whilst high multiple times in the previous month, according to the state Cannabis Control Authority. In other words, that equates to nearly one in five people regularly operating vehicles whilst under the influence. Disturbingly, 30% of respondents believe cannabis users are usually safe drivers.
State-Level Evidence Links Legalisation to Increased Fatalities
Meanwhile, data from states that have legalised recreational cannabis reveals a disturbing pattern. Notably, Washington state witnessed the proportion of drivers involved in fatal collisions who tested positive for THC double after legalisation, from approximately 9% on average in the five years before legalisation to 18% in the subsequent five years.
Similarly, Colorado, an early adopter of cannabis legalisation in 2014, experienced a near doubling of cannabis-related car crash fatalities between 2013 and 2020. Following legalisation in Oregon, Alaska, and California, car crash deaths increased by 22%, 20%, and 14% respectively.
As a result, these statistics suggest that legalisation contributes to increased cannabis-impaired driving incidents, thereby undermining road safety gains achieved through decades of public health initiatives.
The Erosion of Road Safety Culture
Over several decades, America developed a powerful cultural taboo against drink-driving, largely through sustained education and prevention campaigns by organisations such as Mothers Against Drunk Driving (MADD). Subsequently, these efforts fundamentally changed public attitudes and behaviours, saving countless lives.
However, the data indicates that cannabis legalisation has eroded similar taboos against drug-impaired driving. In particular, industry marketing campaigns promoting cannabis as medically beneficial and harmless have contributed to dangerous misperceptions about the drug’s effects on driving ability.
Additionally, the parallels with historic tobacco industry tactics are striking. Decades ago, tobacco companies paid medical professionals and scientists to promote cigarettes as beneficial to health. Today, the cannabis industry employs sophisticated marketing strategies that downplay or ignore the substance’s well-documented risks.
Broader Health Concerns Beyond Road Safety
Nevertheless, the dangers of cannabis extend well beyond impaired driving. Recent studies have linked marijuana use to serious cardiac events, damaged fertility in women, schizophrenia, and other severe mental health conditions. Furthermore, high-profile incidents involving individuals with documented cannabis use have highlighted the drug’s potential connection to violent behaviour.
Consequently, these broader health implications underscore the need for comprehensive approaches to cannabis prevention that address both immediate risks like cannabis-impaired driving and long-term health consequences.
Urgent Need for Prevention and Education
Clearly, the escalating crisis of drug-impaired driving demands immediate action. Therefore, robust awareness and prevention programmes are essential to educate the public, particularly younger drivers, about the deadly dangers of operating vehicles whilst under the influence of cannabis.
In addition, states must reconsider policies that have normalised cannabis use without adequate safeguards or public health protections. Indeed, the rush to legalisation has outpaced understanding of the substance’s risks, thus creating preventable tragedies on roads across the nation.
Moreover, federal authorities should prioritise research into cannabis-impaired driving, develop evidence-based prevention strategies, and support states in implementing effective enforcement and education measures. Ultimately, public health campaigns must counter industry messaging and establish clear understanding that cannabis significantly impairs driving ability.
In conclusion, the evidence is unequivocal: cannabis-impaired driving represents a growing threat to public safety. Only through comprehensive prevention efforts, honest public education, and evidence-based policy can this escalating crisis be addressed effectively.
A comprehensive decade-long study examining drug and alcohol presence in Victorian road crashes has revealed alarming trends, with methylamphetamine emerging as the most prevalent illicit substance detected in both injured and fatally injured drivers between 2010 and 2019.
The research, published in Injury Prevention and led by Monash University, represents the largest investigation of its kind conducted in Australia. Analysing data from 19,843 injured drivers and 1,596 fatalities, the findings paint a concerning picture of drug-impaired driving across Victoria’s roads.
Methylamphetamine Prevalence in Road Crashes Reaches Alarming Levels
The study found that methylamphetamine had the highest prevalence among Victorian drivers involved in crashes. Researchers detected the substance in 12.3% of fatalities and 9.1% of injured drivers, and these detections increased over time.
Taken together, these statistics underscore a growing public health and road safety challenge. In particular, methylamphetamine impairs cognitive function, reaction times, and decision-making abilities, all of which are critical for safe vehicle operation.
Multiple Substances Detected in Victorian Drivers
The research revealed that 16.8% of car drivers and motorcyclists tested positive for one or more drugs. Alcohol remained a significant factor, with 14% of crashes involving a blood alcohol concentration (BAC) at or exceeding 0.05%.
Cannabis (THC) emerged as another substance of concern, with detections rising amongst injured drivers until 2018. The study found THC detected in 8.1% of injured drivers and 15.2% of fatally injured drivers.
MDMA-positive driving decreased amongst injured drivers and remained stable at approximately 1% of fatalities throughout the study period.
Drug-Driving Patterns in Motorcyclists
Motorcyclists emerged as a particularly vulnerable population. Between 2015 and 2019, methylamphetamine was detected in 27.9% of motorcyclist fatalities, a figure substantially higher than the overall driver population. THC followed at 18.3%, with alcohol at or above 0.05% BAC detected in 14.2% of fatal motorcycle crashes. Similar but lower frequencies were observed amongst injured motorcyclists.
These elevated rates amongst motorcyclists warrant particular attention, as riders already face heightened vulnerability on roads due to reduced physical protection compared to enclosed vehicle occupants.
Alcohol Trends Show Mixed Results
The study documented a decline in alcohol detections (≥0.05% BAC) amongst fatalities. However, alcohol detections increased amongst injured motorcyclists and car drivers until plateauing in 2017. This mixed trend suggests that whilst fatal alcohol-related crashes may be decreasing, alcohol continues to contribute significantly to road trauma overall.
Demographics and Risk Factors
The research identified that there was a higher incidence of drug-positive driving amongst men and individuals aged between 25 and 59 years, alongside patterns of increasing drug use in motorcyclists.
Implications for Road Safety Prevention
The comprehensive data from the Victorian Institute of Forensic Medicine and Victoria Police provides robust evidence of persistent drug-impaired driving despite Victoria’s enhanced road safety measures.
Co-senior author Adjunct Associate Professor Dimitri Gerostamoulos from Monash University’s Department of Forensic Medicine and the Victorian Institute of Forensic Medicine stated that the findings confirm methylamphetamine, alcohol, and cannabis are the drugs that cause the most harm on Victorian roads.
The decade-long trends demonstrate that current prevention strategies require re-evaluation and strengthening. The study’s authors concluded that despite enhanced road safety measures in Victoria, drug-driving persists, indicating a need for revised prevention strategies targeting this growing issue.
Addressing the Drug-Driving Challenge
This research provides critical baseline data for policymakers, law enforcement, and public health officials working to reduce drug-driving incidents. The upward trajectory of methylamphetamine detections, combined with persistent alcohol involvement and rising cannabis presence, indicates that impaired driving prevention must remain a priority.
Understanding which substances most frequently impair drivers, and which demographic groups exhibit highest risk, enables targeted prevention initiatives. The particularly high rates of drug detection amongst motorcyclists suggest this group requires specialised attention in prevention messaging and enforcement strategies.
As Victoria continues developing its road safety framework, this evidence base highlights where authorities should concentrate prevention efforts to achieve meaningful reductions in drug and alcohol-related road trauma.
A groundbreaking study from McGill University has revealed alarming connections between early cannabis use and severe long-term health consequences, with researchers documenting substantially elevated risks for both mental and physical health problems amongst young users.
The research, published in JAMA Network Open, examined the relationship between the age at which individuals begin using marijuana and subsequent health outcomes. The findings paint a concerning picture of early cannabis use and its lasting impact on developing minds and bodies.
Staggering Mental and Physical Health Risks
According to the McGill University study, frequent marijuana consumption beginning before age 15 is associated with a 51% higher chance of developing mental health problems later in life. Even more striking, early cannabis use correlates with an 86% increased likelihood of physical health problems.
These figures represent some of the most compelling evidence to date regarding the dangers of teenage marijuana consumption. The researchers defined “frequent use” as consumption at least once monthly—a threshold that many would consider relatively moderate by today’s standards.
Youth Marijuana: A Gateway to Greater Harm
The study’s methodology raises important questions about the true extent of damage caused by early cannabis use. Since the research categorised monthly consumption as “frequent use,” the health implications for daily or near-daily users—particularly common amongst those who begin using during early adolescence—may be considerably more severe.
Research has consistently demonstrated that earlier initiation of marijuana typically leads to more frequent consumption patterns over time. This correlation suggests that the 51% and 86% increased risk figures from the McGill study may represent conservative estimates of the actual health burden associated with youth cannabis consumption amongst the heaviest consumers.
Teenage Brain Development Under Threat
The timing of cannabis initiation proves critical because the adolescent brain undergoes crucial developmental processes that continue into the mid-twenties. Early cannabis use disrupts these processes, potentially causing lasting alterations to brain structure and function.
Mental health problems linked to teenage marijuana consumption include increased rates of depression, anxiety disorders, psychosis, and schizophrenia. The developing brain’s heightened vulnerability to cannabis compounds explains why adolescent exposure carries such pronounced long-term consequences compared to adult-onset use.
Physical Health Consequences of Youth Cannabis Exposure
Whilst public discourse around marijuana often focuses on mental health impacts, the McGill research highlights equally concerning physical health ramifications. The 86% increased risk of physical health problems associated with early cannabis use encompasses respiratory issues, cardiovascular concerns, and immune system disruption.
Chronic cannabis consumption during adolescence has been linked to reduced lung function, increased susceptibility to respiratory infections, and potential long-term cardiovascular complications. These physical manifestations of teenage marijuana use often receive insufficient attention in policy debates around cannabis accessibility.
Policy Implications and Youth Protection
The study’s findings arrive at a crucial juncture in cannabis policy development across numerous jurisdictions. As legalisation and decriminalisation efforts advance globally, the McGill research underscores the imperative of robust youth protection measures.
Evidence demonstrating the severe health consequences of early cannabis use strengthens arguments for stringent age restrictions, comprehensive public education campaigns, and enhanced enforcement mechanisms to prevent teenage access to cannabis products.
The Cumulative Evidence Against Youth Use
The McGill University study joins a growing body of research documenting the particular dangers of starting marijuana before age 15. Longitudinal studies have repeatedly shown that individuals who begin using cannabis during their teenage years face elevated risks across multiple health domains compared to those who abstain or delay use until adulthood.
This accumulating evidence challenges narratives that minimise cannabis harms or suggest the substance poses limited risks to users. The data makes clear that early cannabis use carries profound, measurable consequences that extend far beyond the period of active consumption.
A Clear Message for Young People
With mental health problems rising 51% and physical health problems increasing 86% amongst those who begin frequent marijuana consumption before age 15, the scientific evidence delivers an unambiguous message: teenage cannabis use poses serious, long-term health risks.
The researchers’ findings emphasise that these elevated health risks stem from monthly use—a pattern many might not consider particularly intensive. For young people using cannabis more frequently, the health implications are likely substantially worse.
As communities grapple with evolving cannabis policies, protecting adolescents from early cannabis use must remain paramount. The McGill study provides compelling evidence that preventing youth marijuana consumption represents a critical public health priority with implications extending decades into users’ futures.
The complete study, authored by Martinez P, Chadi N, Castellanos-Ryan N, and colleagues, is available in JAMA Network Open (2025;8(10):e2539977. doi:10.1001/jamanetworkopen.2025.39977). (Source: WRD News)
Background Driving under the influence of alcohol and other drugs contributes significantly to road traffic crashes worldwide. This study explored trends of alcohol, methylamphetamine (MA), 3,4-methylenedioxy-N-methylamphetamine (MDMA) and Δ9-tetrahydrocannabinol (THC), in road crashes from 2010 to 2019 in Victoria, Australia.
Methods We conducted a cross-sectional analysis using data from the Victorian Institute of Forensic Medicine and Victoria Police, examining proscribed drug detections in road crashes. Time series graphs per substance explored indicative trends and comparisons between road users. Negative binomial regression models, with robust SEs and adjusted for exposure (kilometres travelled, Victorian licence holders), modelled the incidence rate ratio, with a Bonferroni-adjusted α=0.007 for multiple comparisons.
Results There were 19 843 injured drivers and 1596 fatally injured drivers. MA had the highest prevalence (12.3% of fatalities and 9.1% of injured drivers), demonstrating an increase over time. Overall, 16.8% of car drivers and motorcyclists tested positive for one or more drugs, with 14% of crashes involving a blood alcohol concentration (BAC)≥0.05%. MA and THC were the most common drugs in fatalities. Between 2015 and 2019, MA was detected in 27.9% of motorcyclist fatalities, followed by THC (18.3%) and alcohol ≥0.05% (14.2%), with similar but lower frequencies among injured motorcyclists. Alcohol detections (≥0.05% BAC) in fatalities declined, but increased in injured motorcyclists and car drivers until plateauing in 2017. THC detections rose among injured drivers until 2018, detected in 8.1% and 15.2% of injured and fatal drivers, respectively. MDMA-positive driving decreased among injured drivers and remained stable at ~1% of fatalities.
Conclusions Despite enhanced road safety measures in Victoria, drug-driving persists, indicating a need for revised prevention strategies targeting this growing issue.
Emerging research is raising alarm bells about a potentially dangerous combination that has become increasingly common amongst young people: cannabis use paired with excessive gaming. Whilst each activity carries its own mental health risks, scientists warn that together they may create a perfect storm for psychotic disorders, particularly in adolescents and young adults.
Recent studies have independently linked both cannabis use and problematic gaming behaviour to psychosis, schizophrenia, and other serious mental health conditions. Now, researchers are examining how these two behaviours interact and why the combination appears to pose amplified risks to vulnerable individuals.
The findings carry urgent implications as cannabis legalisation expands and gaming becomes ever more immersive and time-consuming. Understanding the cannabis and gaming risks is crucial for parents, young people, and healthcare providers navigating this evolving landscape.
The Science Behind Cannabis-Related Psychosis
Cannabis has long been associated with increased risk of psychotic disorders, but recent research has provided clearer insights into the mechanisms involved. A groundbreaking study published in JAMA Psychiatry in April 2025 found that cannabis use disorder is associated with heightened dopamine activity in the same brain pathway involved in psychosis.
This discovery helps explain why cannabis increases psychosis risk at a neurochemical level. The dopamine system, which plays crucial roles in motivation, reward, and reality perception, becomes dysregulated with heavy cannabis use. This dysregulation can trigger psychotic symptoms including hallucinations, delusions, paranoia, and disorganised thinking.
National Institutes of Health data indicates that young men who use marijuana face the highest risk of developing psychotic illnesses like schizophrenia. The developing adolescent brain appears particularly vulnerable to cannabis’s effects, with early use linked to more severe long-term consequences.
A September 2025 study published in the Journal of Psychiatric Research compared psychotic symptoms amongst non-cannabis users, natural cannabis users, and synthetic cannabinoid users. The results were striking: synthetic cannabinoid users experienced the most severe psychotic symptoms, high dissociative symptoms with little improvement over time, and limited recovery from alexithymia (difficulty identifying and expressing emotions).
Natural cannabis users showed elevated dissociation with some improvement, whilst non-users demonstrated higher negative symptoms initially but progressive improvement over six months. The researchers concluded that synthetic cannabinoids are associated with “more severe and persistent psychotic symptoms and emotional dysregulation compared to natural cannabis.”
Gaming Disorder and Mental Health
Gaming disorder, recognised by the World Health Organisation as an addictive behavioural disorder, has emerged as a significant mental health concern. A June 2023 study published in the journal Psychopathology examined the link between gaming disorder and psychotic disorders, noting a significant lack of research on how these conditions interact.
The study found that excessive gaming may act as a trigger for psychotic episodes in some patients, based on multiple case reports. Surprisingly, the sudden disruption of gaming habits could also trigger psychosis, suggesting complex relationships between gaming behaviour and mental health.
A 2023 study in BMC Psychiatry identified insomnia and cyberbullying as key mechanisms linking gaming to psychotic disorders. The researchers concluded that preventing sleep deprivation and cyberbullying can reduce psychosis risk, highlighting how gaming’s impacts extend beyond screen time itself.
Research published in Frontiers in Psychiatry in 2024 found that adolescents and young adults engage in “problematic gaming” much faster than adults. These younger gamers also showed similar psychiatric comorbidities including autism, ADHD, and problematic gambling behaviours.
The speed at which young people develop problematic gaming patterns is concerning. Their developing brains, still forming crucial neural pathways and regulatory systems, appear more susceptible to gaming’s addictive properties and associated mental health impacts.
Why the Combination Amplifies Risk
Whilst research specifically examining cannabis and gaming risks together remains limited, mental health professionals warn that the combination creates particularly dangerous conditions for psychosis development.
Psychotherapist Jonathan Alpert explains that both marijuana use and heavy gaming can “tax the brain in similar ways.” Cannabis has been linked to heightened psychosis risk, especially in younger people or those with family histories of mental illness. Gaming, when excessive, disrupts sleep, increases social isolation, and creates cycles of stress and withdrawal.
“When these habits occur together, the risks can multiply,” Alpert warns. “Poor sleep, altered brain chemistry, and detachment from real-world coping skills can converge to increase vulnerability to paranoia, distorted thinking or even psychotic episodes.”
The lifestyle surrounding these habits compounds the problem. Late nights, poor diet, lack of exercise, and limited face-to-face interaction all strain the brain further. “The result is higher risk for psychosis and also weakened overall mental health,” Alpert notes.
Both activities affect similar neurological systems. Cannabis alters dopamine pathways whilst gaming triggers dopamine releases through reward mechanisms. This dual manipulation of the brain’s reward system may create heightened vulnerability to dysregulation.
Sleep disruption represents another critical factor. Cannabis can interfere with sleep architecture, reducing REM sleep and affecting sleep quality. Gaming, particularly late at night, similarly disrupts normal sleep patterns. The combination often leads to severe sleep deprivation, itself a risk factor for psychotic symptoms.
Social isolation amplifies these risks. Heavy gamers often withdraw from real-world relationships, spending increasing time in virtual environments. Cannabis use can increase paranoia and social anxiety, further driving isolation. Together, they create a feedback loop of withdrawal from healthy social connections that normally buffer against mental health problems.
Real-World Consequences
The theoretical risks of cannabis and gaming have manifested in tragic real-world events. Several recent violent incidents have involved perpetrators who combined heavy cannabis use with excessive gaming, particularly violent video games.
In Minneapolis, the gunman in a mass shooting at Annunciation Catholic Church reportedly worked at a cannabis dispensary and “smoked it all the time,” according to friends. In Dallas, an ICE facility shooter was described by friends as “obsessed with sitting at home, smoking weed, playing video games.” He had reportedly logged more than 10,000 hours of gaming, much of it violent shooting games.
Another case involved a suspect who logged nearly 5,000 hours of solo gameplay before allegedly committing an assassination. These cases don’t prove causation, but they highlight concerning patterns that warrant serious attention.
It’s crucial to note that millions of people game and use cannabis without becoming violent. However, these cases suggest that in vulnerable individuals, particularly those with underlying mental health conditions or genetic predispositions, the combination of cannabis and gaming risks may contribute to catastrophic outcomes.
Age Matters: Young People at Greatest Risk
Research consistently shows that younger individuals face more severe consequences from both cannabis use and gaming. A 2022 NIH-published study found that general substance use in children under 17 years posed greater risk of psychotic-like experiences.
The developing adolescent brain undergoes critical maturation processes, particularly in the prefrontal cortex responsible for decision-making, impulse control, and reality testing. Cannabis use during this developmental window can disrupt these processes, potentially causing lasting changes.
Similarly, young people appear more susceptible to gaming’s addictive properties and associated mental health impacts. They develop problematic gaming patterns faster than adults and show higher rates of psychiatric comorbidities.
“Developing early detection and intervention for both substance use and psychotic-like experiences may reduce long-term adverse outcomes,” researchers concluded in the 2022 study. This highlights the importance of prevention and early intervention, particularly for adolescents.
Parents, educators, and healthcare providers must recognise that what might seem like typical teenage behaviour, such as gaming for hours whilst using cannabis, could actually represent significant mental health risks requiring intervention.
Synthetic Cannabinoids: An Even Greater Threat
The September 2025 Journal of Psychiatric Research study revealed that synthetic cannabinoids pose substantially greater risks than natural cannabis. Synthetic cannabinoid users experienced more severe psychotic symptoms, high dissociative symptoms with little improvement over time, and limited recovery from emotional regulation difficulties.
Synthetic cannabinoids, often marketed as “spice” or “K2,” mimic THC’s psychoactive properties but with much stronger effects. These manufactured compounds are often significantly more potent than natural cannabis and can trigger severe adverse reactions including psychosis, seizures, and cardiovascular problems.
The persistence of symptoms in synthetic cannabinoid users is particularly concerning. Whilst natural cannabis users showed some improvement in dissociative symptoms over time, synthetic users demonstrated little recovery, suggesting potentially more lasting brain changes.
Young people may encounter synthetic cannabinoids without realising what they’re consuming, particularly in jurisdictions where natural cannabis remains illegal. The heightened risks associated with these substances underscore the importance of education about different cannabis products and their varying dangers.
Warning Signs and Risk Factors
Recognising warning signs of emerging problems is crucial for early intervention. For cannabis use, red flags include increasing tolerance (needing more to achieve the same effect), unsuccessful attempts to cut down, continued use despite negative consequences, and withdrawal symptoms when not using.
Gaming-related warning signs include gaming for increasingly long periods, unsuccessful attempts to reduce gaming time, loss of interest in other activities, continued gaming despite negative consequences, deceiving others about gaming time, and using gaming to escape negative moods.
When cannabis and gaming risks combine, additional warning signs may emerge including severe sleep disruption, increased social withdrawal, paranoid thoughts or behaviours, difficulty distinguishing between gaming and reality, neglect of personal hygiene and health, and deteriorating academic or work performance.
Risk factors for psychosis include family history of psychotic disorders, early cannabis use (particularly before age 16), high-potency cannabis use, frequent or daily use, synthetic cannabinoid use, pre-existing mental health conditions, social isolation, and stressful life circumstances.
Individuals with multiple risk factors require particular vigilance. Someone with a family history of schizophrenia who begins using high-potency cannabis daily whilst gaming excessively faces substantially elevated risk.
The Policy Debate
These findings emerge as the United States considers reclassifying marijuana as a Schedule III drug, touting medicinal benefits of CBD. This policy shift would reflect growing acceptance of cannabis for medical purposes whilst maintaining some regulatory oversight.
However, the research on cannabis and gaming risks highlights the complexity of cannabis policy. Whilst CBD and other cannabinoids may offer genuine medical benefits for certain conditions, recreational cannabis use, particularly by young people, carries serious mental health risks.
Legalisation has increased cannabis potency and accessibility. Today’s legal cannabis products often contain THC concentrations far exceeding what was available decades ago. High-potency products pose greater psychosis risks, yet remain widely available in legal markets.
Some medical professionals argue that legalisation has worsened mental health outcomes. “Legalising cannabis isn’t helping matters, it’s making things worse,” warns Dr Drew Pinsky, pointing to increased cannabis use disorder rates and psychosis cases in legalised jurisdictions.
Balancing potential medical benefits against recreational use risks remains contentious. Clear age restrictions, potency limits, required health warnings, and robust public education represent potential harm-reduction measures, but their effectiveness varies.
Prevention and Intervention Strategies
Given the identified risks, what can be done to protect vulnerable individuals, particularly young people? Prevention must start with education. Young people, parents, and educators need accurate information about cannabis and gaming risks, particularly when combined.
Schools should incorporate mental health and substance use education into curricula, covering not just traditional drugs but also cannabis and behavioural addictions like gaming. This education should be evidence-based, acknowledging both risks and realities without resorting to scare tactics that undermine credibility.
Parents should monitor their children’s gaming habits and substance use without being overly intrusive. Open, non-judgemental conversations about these topics create environments where young people feel comfortable seeking help if problems develop.
Healthcare providers should routinely screen adolescents and young adults for both substance use and gaming behaviours. Early identification of problematic patterns enables intervention before serious consequences develop.
For those already experiencing problems, evidence-based treatments exist. Cognitive behavioural therapy has proven effective for both cannabis use disorder and gaming disorder. Motivational interviewing can help individuals recognise problems and commit to change.
In cases where psychotic symptoms have emerged, prompt psychiatric evaluation is essential. Early intervention in psychosis can significantly improve long-term outcomes. Treatment may include antipsychotic medications, psychotherapy, and addressing underlying substance use or behavioural issues.
Family involvement often enhances treatment effectiveness. Family therapy can address relationship patterns that may contribute to problematic behaviours whilst strengthening support systems crucial for recovery.
Creating Healthier Lifestyles
Beyond addressing cannabis and gaming specifically, promoting overall mental health and healthy lifestyles provides protective benefits. Regular exercise, consistent sleep schedules, nutritious diet, and meaningful social connections all support mental wellbeing and resilience.
Encouraging diverse interests and activities prevents over-reliance on any single behaviour for entertainment or stress relief. Young people with varied hobbies, strong social networks, and healthy coping strategies are less likely to develop problematic gaming or substance use patterns.
Stress management skills represent another crucial protective factor. Teaching young people healthy ways to manage stress, anxiety, and difficult emotions reduces the appeal of cannabis or gaming as escape mechanisms.
Communities can support these efforts by providing accessible recreational facilities, youth programmes, mental health services, and substance use treatment. Creating environments where young people have opportunities for healthy engagement and readily available help when needed represents sound investment in public health.
The Need for More Research
Despite growing recognition of cannabis and gaming risks, researchers note significant gaps in understanding how these behaviours interact. The June 2023 Psychopathology study specifically noted the lack of research on gaming disorder and psychotic disorder interactions.
More research is needed examining the combined effects of cannabis use and gaming on brain development, particularly in adolescents. Longitudinal studies following young people over time could reveal how these behaviours interact and what factors increase or decrease risk.
Research should also examine whether certain types of games pose greater risks. Do violent games contribute more to psychosis risk than other genres? Does the social isolation of solo gaming matter more than the content?
Understanding protective factors is equally important. Why do some individuals use cannabis and game heavily without developing psychosis whilst others do? Identifying resilience factors could inform more targeted prevention efforts.
The researchers behind the September 2025 study emphasised that “these findings underscore the need for targeted interventions addressing emotional regulation and salience processing in cannabis-related psychosis.” This highlights how research should directly inform treatment development.
A Balanced Perspective
Whilst the research on cannabis and gaming risks is concerning, maintaining perspective is important. Millions of people game regularly and use cannabis without developing psychosis or serious mental health problems. The vast majority of gamers and cannabis users will not experience these severe outcomes.
However, for vulnerable individuals, particularly young people with risk factors like family history of mental illness or early cannabis initiation, the risks are genuine and potentially life-altering. “Not that every gamer or cannabis user is at risk, but this cocktail of behaviours creates an unhealthy lifestyle that leaves people far more vulnerable to serious consequences,” notes psychotherapist Alpert.
The goal isn’t to demonise gaming or cannabis use but to ensure people make informed decisions based on accurate risk information. Young people deserve to understand how their choices might affect their mental health, particularly when multiple risk factors combine.
Looking Forward
As society continues grappling with cannabis legalisation and the proliferation of immersive gaming, the research on their combined mental health impacts will only grow more relevant. Policymakers, healthcare providers, educators, and parents must stay informed about emerging evidence and adapt approaches accordingly.
The studies examining cannabis and gaming risks represent important steps toward understanding how modern lifestyle factors interact to influence mental health. By taking these findings seriously and implementing evidence-based prevention and intervention strategies, we can work to protect vulnerable individuals whilst respecting personal autonomy.
For young people already combining heavy cannabis use with excessive gaming, particularly those experiencing concerning symptoms like paranoia, social withdrawal, or difficulty distinguishing reality, seeking professional help is crucial. Early intervention can prevent progression to full psychotic disorders and improve long-term outcomes.
The message is clear: whilst neither gaming nor cannabis use inevitably leads to psychosis, their combination in vulnerable individuals creates heightened risk that warrants serious attention. Understanding and responding to these risks represents an important public health priority in an era of widespread cannabis use and ubiquitous gaming culture. (Source: WRD News)
World Federation Against Drugs (W.F.A.D) Dalgarno Institute is a member of this global initiative. For evidence based data on best practice drug policy in the global context.
The Institute for Behavior and Health, Inc. is to reduce the use of illegal drugs. We work to achieve this mission by conducting research, promoting ideas that are affordable and scalable...
Drug Free Australia Website. Drug Free Australia is a peak body, representing organizations and individuals who value the health and wellbeing of our nation...
(I.T.F.S.D.P) This international peak body continues to monitor and influence illicit drug policy on the international stage. Dalgarno Institute is a member organisation.
The National Alliance for Action on Alcohol is a national coalition of health and community organisations from across Australia that has been formed with the goal of reducing alcohol-related harm.
RiverMend Health is a premier provider of scientifically driven, specialty behavioral health services to those suffering from alcohol and drug dependency, dual disorders, eating disorders, obesity and chronic pain.